Literature DB >> 8461992

Effects of estrogen upon dopamine release from the corpus striatum of young and aged female rats.

J L McDermott1.   

Abstract

In vitro superfusion was used to examine the effects of estrogen administration upon striatal dopamine release in ovariectomized young and aged female Fischer 344 rats in response to 10 microM amphetamine or 30 mM potassium stimulation. Estrogen treatment increased basal dopamine and decreased DOPAC release in young and aged females (10 micrograms estradiol benzoate given subcutaneously 24 and 48 h prior to superfusion). Amphetamine-stimulated dopamine release was significantly decreased in aged estrogen-treated females, but did not differ in young females as a function of estrogen treatment. Conversely, young females treated with estrogen showed significantly decreased striatal dopamine release in response to potassium stimulation, while aged females showed no differences as a function of hormone treatment. Striatal dopamine content was significantly decreased in all estrogen-treated young and aged females. It appears that estrogen is altering dopamine uptake mechanisms in both age groups, since basal DOPAC release is decreased and dopamine is increased. This estrogen effect depletes the readily releasable dopamine storage pool to a greater extent in the aged female as evidenced by reduced amphetamine-stimulated dopamine release. By contrast, estrogen does not alter vesicular dopamine storage pools in aged females, which are mobilized by potassium. These results may have important implications regarding sex differences in expression and treatment of age-related movement disorders.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8461992     DOI: 10.1016/0006-8993(93)91578-g

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males.

Authors:  Michal Arad; Ina Weiner
Journal:  Neuropsychopharmacology       Date:  2010-07-07       Impact factor: 7.853

2.  Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis?

Authors:  Michal Arad; Ina Weiner
Journal:  Neuropsychopharmacology       Date:  2010-03-17       Impact factor: 7.853

3.  Investigating sex differences and the effect of drug exposure order in the sensory reward-enhancing effects of nicotine and d-amphetamine alone and in combination.

Authors:  Kathleen R McNealy; Sydney D Houser; Scott T Barrett; Rick A Bevins
Journal:  Neuropharmacology       Date:  2021-10-19       Impact factor: 5.250

4.  The effects of long-term treatment with estradiol and medroxyprogesterone acetate on tyrosine hydroxylase fibers and neuron number in the medial prefrontal cortex of aged female rats.

Authors:  Nioka C Chisholm; Alexandria R Packard; Wendy A Koss; Janice M Juraska
Journal:  Endocrinology       Date:  2012-08-17       Impact factor: 4.736

5.  Estrogen ameliorates microglial activation by inhibiting the Kir2.1 inward-rectifier K(+) channel.

Authors:  Shih-Ying Wu; Yun-Wen Chen; Sheng-Feng Tsai; Sheng-Nan Wu; Yao-Hsiang Shih; Ya-Fen Jiang-Shieh; Ting-Ting Yang; Yu-Min Kuo
Journal:  Sci Rep       Date:  2016-03-10       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.